A detailed history of Envestnet Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Envestnet Asset Management Inc holds 1,953,697 shares of NVS stock, worth $190 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,953,697
Previous 1,928,853 1.29%
Holding current value
$190 Million
Previous $205 Million 9.43%
% of portfolio
0.07%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$106.13 - $120.89 $2.64 Million - $3 Million
24,844 Added 1.29%
1,953,697 $225 Million
Q2 2024

Aug 08, 2024

SELL
$92.57 - $107.37 $2.24 Million - $2.6 Million
-24,199 Reduced 1.24%
1,928,853 $205 Million
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $7.53 Million - $8.58 Million
-79,078 Reduced 3.89%
1,953,052 $189 Million
Q4 2023

Feb 13, 2024

SELL
$92.27 - $101.54 $1.64 Million - $1.8 Million
-17,771 Reduced 0.87%
2,032,130 $205 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $65.1 Million - $72.2 Million
686,847 Added 50.39%
2,049,901 $209 Million
Q2 2023

Aug 04, 2023

SELL
$92.52 - $104.91 $657 Million - $745 Million
-7,098,392 Reduced 83.89%
1,363,054 $138 Million
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $567 Million - $658 Million
7,085,365 Added 514.89%
8,461,446 $778 Million
Q4 2022

Feb 07, 2023

BUY
$75.55 - $92.52 $1.02 Million - $1.25 Million
13,487 Added 0.99%
1,376,081 $125 Million
Q3 2022

Nov 10, 2022

BUY
$74.61 - $87.26 $7.91 Million - $9.25 Million
105,955 Added 8.43%
1,362,594 $104 Million
Q2 2022

Aug 03, 2022

BUY
$80.52 - $93.75 $4.15 Million - $4.83 Million
51,511 Added 4.27%
1,256,639 $106 Million
Q1 2022

May 04, 2022

BUY
$80.11 - $90.62 $12 Million - $13.6 Million
150,297 Added 14.25%
1,205,128 $106 Million
Q4 2021

Feb 04, 2022

SELL
$79.7 - $88.13 $1.28 Million - $1.42 Million
-16,059 Reduced 1.5%
1,054,831 $92.3 Million
Q3 2021

Oct 07, 2021

BUY
$81.78 - $95.14 $2.88 Million - $3.35 Million
35,192 Added 3.4%
1,070,890 $87.6 Million
Q2 2021

Aug 04, 2021

BUY
$85.24 - $94.15 $6.62 Million - $7.31 Million
77,686 Added 8.11%
1,035,698 $94.5 Million
Q1 2021

May 04, 2021

BUY
$83.5 - $98.47 $8.02 Million - $9.46 Million
96,024 Added 11.14%
958,012 $81.9 Million
Q4 2020

Feb 02, 2021

BUY
$78.07 - $94.43 $1.84 Million - $2.22 Million
23,536 Added 2.81%
861,988 $81.4 Million
Q3 2020

Oct 09, 2020

SELL
$82.14 - $91.0 $3.83 Million - $4.25 Million
-46,687 Reduced 5.27%
838,452 $72.9 Million
Q2 2020

Jul 08, 2020

BUY
$80.93 - $91.1 $7.81 Million - $8.79 Million
96,460 Added 12.23%
885,139 $77.3 Million
Q1 2020

Apr 23, 2020

BUY
$70.67 - $99.01 $7.09 Million - $9.93 Million
100,310 Added 14.57%
788,679 $65 Million
Q4 2019

Feb 11, 2020

BUY
$84.35 - $95.37 $5.12 Million - $5.78 Million
60,658 Added 9.66%
688,369 $65.2 Million
Q3 2019

Oct 17, 2019

BUY
$85.54 - $94.26 $7.35 Million - $8.1 Million
85,936 Added 15.86%
627,711 $54.5 Million
Q2 2019

Aug 02, 2019

SELL
$75.4 - $92.8 $1.75 Million - $2.16 Million
-23,268 Reduced 4.12%
541,775 $49.5 Million
Q1 2019

May 10, 2019

BUY
$75.32 - $86.15 $2.43 Million - $2.78 Million
32,228 Added 6.05%
565,043 $54.3 Million
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $34.3 Million - $38.1 Million
464,999 Added 685.68%
532,815 $45.7 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $7.45 Million - $8.62 Million
-111,327 Reduced 62.14%
67,816 $5.84 Million
Q2 2018

Aug 10, 2018

BUY
$64.91 - $73.36 $3.88 Million - $4.39 Million
59,795 Added 50.1%
179,143 $13.5 Million
Q1 2018

May 09, 2018

SELL
$70.39 - $84.15 $35.4 Million - $42.4 Million
-503,494 Reduced 80.84%
119,348 $9.62 Million
Q4 2017

Feb 20, 2018

BUY
$72.33 - $77.64 $122,671 - $131,677
1,696 Added 0.27%
622,842 $52.3 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $1.46 Million - $1.52 Million
19,704 Added 3.28%
621,146 $53.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
601,442
601,442 $50.2 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.